1-7 of 7
Milo Frattini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Dose-Escalation Study of the Dual PI3K-mTORC1/2 Inhibitor Gedatolisib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors

Ilaria Colombo, Sofia Genta, Federica Martorana, Monia Guidi, Milo Frattini, Eleftherios Pierre Samartzis, Simone Brandt, Sheila Gaggetta, Laura Moser, Mariarosa Pascale, Tatiana Terrot, Cristiana Sessa, Anastasios Stathis
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (18): 5012–5019.
https://doi.org/10.1158/1078-0432.CCR-21-1402
Published: 15 September 2021
View article titled, Phase I Dose-Escalation Study of the Dual PI3K-mTORC1/2 Inhibitor Gedatolisib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors
Open the PDF for Phase I Dose-Escalation Study of the Dual PI3K-mTORC1/2 Inhibitor Gedatolisib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors in another window
Includes: Supplementary data
Journal Articles

KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors

Claudia Miranda, Martina Nucifora, Francesca Molinari, Elena Conca, Maria Chiara Anania, Andrea Bordoni, Piercarlo Saletti, Luca Mazzucchelli, Silvana Pilotti, Marco A. Pierotti, Elena Tamborini, Angela Greco, Milo Frattini
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (6): 1769–1776.
https://doi.org/10.1158/1078-0432.CCR-11-2230
Published: 14 March 2012
View article titled, KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors
Open the PDF for KRAS and BRAF Mutations Predict Primary Resistance to Imatinib in Gastrointestinal Stromal Tumors in another window
Includes: Supplementary data
Journal Articles

Increased Detection Sensitivity for KRAS Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer

Francesca Molinari, Lara Felicioni, Michela Buscarino, Sara De Dosso, Fiamma Buttitta, Sara Malatesta, Alessandra Movilia, Marco Luoni, Renzo Boldorini, Oscar Alabiso, Salvatore Girlando, Barbara Soini, Alessandra Spitale, Federica Di Nicolantonio, Piercarlo Saletti, Stefano Crippa, Luca Mazzucchelli, Antonio Marchetti, Alberto Bardelli, Milo Frattini
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (14): 4901–4914.
https://doi.org/10.1158/1078-0432.CCR-10-3137
Published: 17 July 2011
View article titled, Increased Detection Sensitivity for <em>KRAS</em> Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer
Open the PDF for Increased Detection Sensitivity for <em>KRAS</em> Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer in another window
Journal Articles

Cyclooxygenase-2 and Platelet-Derived Growth Factor Receptors as Potential Targets in Treating Aggressive Fibromatosis

Stefano Signoroni, Milo Frattini, Tiziana Negri, Elisa Pastore, Elena Tamborini, Paola Casieri, Marta Orsenigo, Luca Da Riva, Paolo Radice, Paola Sala, Alessandro Gronchi, Lucio Bertario, Marco A. Pierotti, Silvana Pilotti
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (17): 5034–5040.
https://doi.org/10.1158/1078-0432.CCR-07-0336
Published: 04 September 2007
View article titled, Cyclooxygenase-2 and Platelet-Derived Growth Factor Receptors as Potential Targets in Treating Aggressive Fibromatosis
Open the PDF for Cyclooxygenase-2 and Platelet-Derived Growth Factor Receptors as Potential Targets in Treating Aggressive Fibromatosis in another window
Journal Articles

Homeodomain-Interacting Protein Kinase-2 Restrains Cytosolic Phospholipase A2–Dependent Prostaglandin E2 Generation in Human Colorectal Cancer Cells

Gabriella D'Orazi, Maria Gina Sciulli, Valeria Di Stefano, Sabrina Riccioni, Milo Frattini, Rita Falcioni, Lucio Bertario, Ada Sacchi, Paola Patrignani
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (3): 735–741.
https://doi.org/10.1158/1078-0432.CCR-05-1557
Published: 07 February 2006
View article titled, Homeodomain-Interacting Protein Kinase-2 Restrains Cytosolic Phospholipase A<sub>2</sub>–Dependent Prostaglandin E<sub>2</sub> Generation in Human Colorectal Cancer Cells
Open the PDF for Homeodomain-Interacting Protein Kinase-2 Restrains Cytosolic Phospholipase A<sub>2</sub>–Dependent Prostaglandin E<sub>2</sub> Generation in Human Colorectal Cancer Cells in another window
Journal Articles

Different Genetic Features Associated with Colon and Rectal Carcinogenesis

Milo Frattini, Debora Balestra, Simona Suardi, Maria Oggionni, Paola Alberici, Paolo Radice, Aurora Costa, Maria Grazia Daidone, Ermanno Leo, Silvana Pilotti, Lucio Bertario, Marco A. Pierotti
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (12): 4015–4021.
https://doi.org/10.1158/1078-0432.CCR-04-0031
Published: 24 June 2004
View article titled, Different Genetic Features Associated with Colon and Rectal Carcinogenesis
Open the PDF for Different Genetic Features Associated with Colon and Rectal Carcinogenesis in another window
Journal Articles

p16 INK4A Hypermethylation Detected by Fluorescent Methylation-specific PCR in Plasmas from Non-Small Cell Lung Cancer

Alessandra Bearzatto, Davide Conte, Milo Frattini, Nadia Zaffaroni, Francesca Andriani, Debora Balestra, Luca Tavecchio, Maria Grazia Daidone, Gabriella Sozzi
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (12): 3782–3787.
Published: 01 December 2002
View article titled, <em>p16</em> <sup> <em>INK4A</em> </sup> Hypermethylation Detected by Fluorescent Methylation-specific PCR in Plasmas from Non-Small Cell Lung Cancer
Open the PDF for <em>p16</em> <sup> <em>INK4A</em> </sup> Hypermethylation Detected by Fluorescent Methylation-specific PCR in Plasmas from Non-Small Cell Lung Cancer in another window